Identification of a novel binding site for platelet integrins α IIbβ3 (GPIIbIIIa) and α5β 1 in the γC-domain of fibrinogen

Nataly Podolnikova, Valentin P. Yakubenko, George L. Volkov, Edward F. Plow, Tatiana Ugarova

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The interactions of platelets with fibrinogen mediate a variety of responses including adhesion, platelet aggregation, and fibrin clot retraction. Whereas it was assumed that interactions of the platelet integrin α IIbβ3 with the AGDV sequence in the γC-domain of fibrinogen and/or RGD sites in the Aα chains are involved in clot retraction and adhesion, recent data demonstrated that fibrinogen lacking these sites still supported clot retraction. These findings suggested that an unknown site in fibrinogen and/or other integrins participate in clot retraction. Here we have identified a sequence within γC that mediates binding of fibrinogen to platelets. Synthetic peptide duplicating the 365-383 sequence in γC, designated P3, efficiently inhibited clot retraction in a dose-dependent manner. Furthermore, P3 supported platelet adhesion and was an effective inhibitor of platelet adhesion to fibrinogen fragments. Analysis of overlapping peptides spanning P3 and mutant recombinant γC-domains demonstrated that the P3 activity is contained primarily within γ370-383. Integrins αIIbβ3 and α 5β1 were implicated in recognition of P3, since platelet adhesion to the peptide was blocked by function-blocking monoclonal antibodies against these receptors. Direct evidence that α IIbβ3 and α5β1 bind P3 was obtained by selective capture of these integrins from platelet lysates using a P3 affinity matrix. Thus, these data suggest that the P3 sequence in the γC-domain of fibrinogen defines a previously unknown recognition specificity of αIIbβ3 and α 5β1 and may function as a binding site for these integrins.

Original languageEnglish (US)
Pages (from-to)32251-32258
Number of pages8
JournalJournal of Biological Chemistry
Volume278
Issue number34
DOIs
StatePublished - Aug 22 2003
Externally publishedYes

Fingerprint

Clot Retraction
Platelets
Integrins
Fibrinogen
Blood Platelets
Binding Sites
Adhesion
Peptides
Blocking Antibodies
Fibrin
Platelet Aggregation
Agglomeration
Monoclonal Antibodies

ASJC Scopus subject areas

  • Biochemistry

Cite this

Identification of a novel binding site for platelet integrins α IIbβ3 (GPIIbIIIa) and α5β 1 in the γC-domain of fibrinogen. / Podolnikova, Nataly; Yakubenko, Valentin P.; Volkov, George L.; Plow, Edward F.; Ugarova, Tatiana.

In: Journal of Biological Chemistry, Vol. 278, No. 34, 22.08.2003, p. 32251-32258.

Research output: Contribution to journalArticle

@article{36ac7ead0bbb482cb3e21337f922dfa4,
title = "Identification of a novel binding site for platelet integrins α IIbβ3 (GPIIbIIIa) and α5β 1 in the γC-domain of fibrinogen",
abstract = "The interactions of platelets with fibrinogen mediate a variety of responses including adhesion, platelet aggregation, and fibrin clot retraction. Whereas it was assumed that interactions of the platelet integrin α IIbβ3 with the AGDV sequence in the γC-domain of fibrinogen and/or RGD sites in the Aα chains are involved in clot retraction and adhesion, recent data demonstrated that fibrinogen lacking these sites still supported clot retraction. These findings suggested that an unknown site in fibrinogen and/or other integrins participate in clot retraction. Here we have identified a sequence within γC that mediates binding of fibrinogen to platelets. Synthetic peptide duplicating the 365-383 sequence in γC, designated P3, efficiently inhibited clot retraction in a dose-dependent manner. Furthermore, P3 supported platelet adhesion and was an effective inhibitor of platelet adhesion to fibrinogen fragments. Analysis of overlapping peptides spanning P3 and mutant recombinant γC-domains demonstrated that the P3 activity is contained primarily within γ370-383. Integrins αIIbβ3 and α 5β1 were implicated in recognition of P3, since platelet adhesion to the peptide was blocked by function-blocking monoclonal antibodies against these receptors. Direct evidence that α IIbβ3 and α5β1 bind P3 was obtained by selective capture of these integrins from platelet lysates using a P3 affinity matrix. Thus, these data suggest that the P3 sequence in the γC-domain of fibrinogen defines a previously unknown recognition specificity of αIIbβ3 and α 5β1 and may function as a binding site for these integrins.",
author = "Nataly Podolnikova and Yakubenko, {Valentin P.} and Volkov, {George L.} and Plow, {Edward F.} and Tatiana Ugarova",
year = "2003",
month = "8",
day = "22",
doi = "10.1074/jbc.M300410200",
language = "English (US)",
volume = "278",
pages = "32251--32258",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "34",

}

TY - JOUR

T1 - Identification of a novel binding site for platelet integrins α IIbβ3 (GPIIbIIIa) and α5β 1 in the γC-domain of fibrinogen

AU - Podolnikova, Nataly

AU - Yakubenko, Valentin P.

AU - Volkov, George L.

AU - Plow, Edward F.

AU - Ugarova, Tatiana

PY - 2003/8/22

Y1 - 2003/8/22

N2 - The interactions of platelets with fibrinogen mediate a variety of responses including adhesion, platelet aggregation, and fibrin clot retraction. Whereas it was assumed that interactions of the platelet integrin α IIbβ3 with the AGDV sequence in the γC-domain of fibrinogen and/or RGD sites in the Aα chains are involved in clot retraction and adhesion, recent data demonstrated that fibrinogen lacking these sites still supported clot retraction. These findings suggested that an unknown site in fibrinogen and/or other integrins participate in clot retraction. Here we have identified a sequence within γC that mediates binding of fibrinogen to platelets. Synthetic peptide duplicating the 365-383 sequence in γC, designated P3, efficiently inhibited clot retraction in a dose-dependent manner. Furthermore, P3 supported platelet adhesion and was an effective inhibitor of platelet adhesion to fibrinogen fragments. Analysis of overlapping peptides spanning P3 and mutant recombinant γC-domains demonstrated that the P3 activity is contained primarily within γ370-383. Integrins αIIbβ3 and α 5β1 were implicated in recognition of P3, since platelet adhesion to the peptide was blocked by function-blocking monoclonal antibodies against these receptors. Direct evidence that α IIbβ3 and α5β1 bind P3 was obtained by selective capture of these integrins from platelet lysates using a P3 affinity matrix. Thus, these data suggest that the P3 sequence in the γC-domain of fibrinogen defines a previously unknown recognition specificity of αIIbβ3 and α 5β1 and may function as a binding site for these integrins.

AB - The interactions of platelets with fibrinogen mediate a variety of responses including adhesion, platelet aggregation, and fibrin clot retraction. Whereas it was assumed that interactions of the platelet integrin α IIbβ3 with the AGDV sequence in the γC-domain of fibrinogen and/or RGD sites in the Aα chains are involved in clot retraction and adhesion, recent data demonstrated that fibrinogen lacking these sites still supported clot retraction. These findings suggested that an unknown site in fibrinogen and/or other integrins participate in clot retraction. Here we have identified a sequence within γC that mediates binding of fibrinogen to platelets. Synthetic peptide duplicating the 365-383 sequence in γC, designated P3, efficiently inhibited clot retraction in a dose-dependent manner. Furthermore, P3 supported platelet adhesion and was an effective inhibitor of platelet adhesion to fibrinogen fragments. Analysis of overlapping peptides spanning P3 and mutant recombinant γC-domains demonstrated that the P3 activity is contained primarily within γ370-383. Integrins αIIbβ3 and α 5β1 were implicated in recognition of P3, since platelet adhesion to the peptide was blocked by function-blocking monoclonal antibodies against these receptors. Direct evidence that α IIbβ3 and α5β1 bind P3 was obtained by selective capture of these integrins from platelet lysates using a P3 affinity matrix. Thus, these data suggest that the P3 sequence in the γC-domain of fibrinogen defines a previously unknown recognition specificity of αIIbβ3 and α 5β1 and may function as a binding site for these integrins.

UR - http://www.scopus.com/inward/record.url?scp=0041355237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041355237&partnerID=8YFLogxK

U2 - 10.1074/jbc.M300410200

DO - 10.1074/jbc.M300410200

M3 - Article

C2 - 12799374

AN - SCOPUS:0041355237

VL - 278

SP - 32251

EP - 32258

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 34

ER -